InnoSer

Founded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) supporting discovery and preclinical development of drugs. InnoSer’s offerings include PDXO screening platform for oncology, ADPKD mouse model for nephrology, and validated midbrain organoid model for Parkinson’s disease. It also provides pathology, in-vivo imaging and genetically engineered mice model services like colony management, cryopreservation, sanitation/rederivation.

Visit our kfg page to learn more www.innoserlaboratories.com/kfg2020